IeB Perspective: Underscoring the growing opportunities in addressing drug shortages and advancing complex generics with limited competition, pharma companies and CROs should focus on innovative peptide-based therapeutics, proactive regulatory engagement, and leveraging FDA programs like pre-ANDA for accelerated approvals
The most common include: Nausea Diarrhea or constipation Fatigue Bloating Injection site irritation These side effects typically lessen as your body adjusts to the medication
Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection
Conditions frequently comorbid with obesityincluding type 2 diabetes, sleep apnea, and cardiovascular diseasealso negatively affect male fertility by reducing blood flow, increasing inflammation, and depleting antioxidant defenses in reproductive tissue
And per commentary from Eli Lilly leadership, whose ads you probably saw 100,000 times during Olympics coverage, the tirzepatide GLP-1 shortage is coming to an end very soon. There are 50+ mentions of obesity and weight in Hims & Hers Q2 call
C., Matheus, V
